AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, K.
Right arrow Articles by Aburano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, K.
Right arrow Articles by Aburano, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2001; 177:1091-1093
© American Roentgen Ray Society


Technical Innovation

Selective Balloon-Occluded Retrograde Sclerosis of Gastric Varices Using a Coaxial Microcatheter System

Koji Takahashi1, Tomonori Yamada1, Hideki Hyodoh2, Taihei Yoshikawa3, Ryuji Katada4, Kenichi Nagasawa1 and Tamio Aburano1

1 Department of Radiology, Asahiakawa Medical College, 2-1-1-1 Midorigaoka-higashi, Asahikawa, Japan, 078-8510.
2 Department of Radiology, Sapporo Medical University, Minami1-nishi 16 Chuo-ku, Sapporo, 060-8543, Japan.
3 Department of Radiology, Sapporo Higashi Tokushukai Hospital, Kita 33-higashi 13-3-21 Higashi-ku, Sapporo, 065-0033, Japan.
4 Department of Radiology, Sapporo Tokushukai Hospital, 18-4-10 Sakaedori, Shiroishi-ku, Sapporo, 003, Japan.

Received April 2, 2001; accepted after revision May 29, 2001.

 
Address correspondence to K. Takahashi.


Introduction
Top
Introduction
Materials and Methods
Results
Discussion
References
 
In patients with esophageal varices, endoscopic sclerotherapy is accepted as the treatment of choice and is now widely performed. However, endoscopic sclerotherapy is not always effective for the treatment of gastric varices because of their rapid blood flow and the technical difficulty of the procedure. Recently, balloon-occluded retrograde transvenous sclerosis has been used for the treatment of gastric varices, instead of endoscopic and surgical treatment procedures [1,2,3,4,5,6]. Balloon-occluded retrograde sclerotherapy is indicated for gastric varices that drain into the left renal vein through the left adrenal vein.

We developed a method of balloon-occluded retrograde sclerosis, using a coaxial microcatheter, with which we can selectively obliterate the gastric varices while maintaining patency of the gastrorenal shunt. Compared with a standard method of balloon-occluded retrograde sclerotherapy, an advantage of our procedure is that we can sclerose the varices while still maintaining the patent shunt. Our objective is to describe a new way of performing balloon-occluded retrograde sclerosis of gastric varices.


Materials and Methods
Top
Introduction
Materials and Methods
Results
Discussion
References
 
This study comprised 15 patients who, between April 1995 and October 2000, underwent balloon-occluded retrograde sclerosis for the treatment of gastric varices. All patients (seven men and eight women; mean age, 70 years) had undergone fiberoptic endoscopy and were found to have high risk of rupture. Gastric varices were associated with portal hypertension due to liver cirrhosis and were located at the gastric fundus in all patients. Contrast-enhanced CT and celiac and superior mesenteric angiography were performed before the procedure to evaluate the location and the size of the gastric varices and confirm the presence of a gastrorenal shunt. The diameter of the gastrorenal shunt vessel was measured on CT images. The efficacy of balloon-occluded retrograde sclerosis was evaluated by contrast-enhanced CT or fiberoptic endoscopy performed in the follow-up period, ranging from 4 to 36 months (mean, 21 months). The sclerosant was a mixture of equal amounts of 10% ethanolamine oleate (Oldamine; Mochida Pharmaceutical, Tokyo, Japan) and nonionic contrast medium (iopamidol, 300 mg I/mL, Iopamiron 300; Japan Schering, Osaka, Japan).

In the standard method of balloon-occluded retrograde sclerosis (Fig. 1A), a balloon catheter was inserted into and inflated at the left adrenal vein just above its confluence into the left renal vein. Varicography was performed with the inflated balloon catheter to evaluate the size and location of gastric varices, the collateral vessels to the systemic circulation, the amount of sclerosant to be injected, and the position of the balloon catheter. The sclerosant was injected into the left adrenal vein until it completely filled the gastric varices, and both structures were obliterated after the procedure. In patients in whom a varicography showed prominent collateral vessels, including superior phrenic vein and pericardial vein, embolization of these collateral vessels was occasionally needed to prevent inflow of the sclerosant to the systemic circulation.



View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. Balloon-occluded retrograde transvenous sclerosis. Drawing shows that in standard balloon-occluded retrograde transvenous sclerosis, balloon catheter is inserted into and inflated at left adrenal vein just above left renal vein (long arrow). After varicography to evaluate anatomic details of gastric varices and position of balloon catheter, sclerosant is injected into entire portion of gastric varices and gastrorenal shunt (shaded area). Embolization of collateral vessels (short arrow) from gastrorenal shunts to systemic circulation is occasionally needed for prevention of flow of sclerosant into systemic circulation in patients for whom varicography has shown prominent collateral vessels. IVC = inferior vena cava.

 

In balloon-occluded retrograde sclerosis with a coaxial microcatheter (Fig. 1B), IV catheterization was performed from the right internal jugular vein with an 8-French J-shaped long introducer (S-one sheath; Clinical Supply, Gifu, Japan). A 5-French balloon catheter (Selecon balloon catheter; Clinical Supply) was advanced into the left adrenal vein at the highest position possible to prevent its occlusion by sclerotherapy. A 2.9-French microcatheter was then selectively inserted into the gastric varices through an inflated balloon catheter. Sclerosant was injected through the microcatheter to fill the gastric varices, and it remained in the varices for 40 min during balloon occlusion. We left the microcatheter in the gastric varices during those 40 min, and then we withdrew as much of the sclerosant as possible through the microcatheter. During sclerotherapy, 4000 U of human haptoglobin were administered IV to prevent renal insufficiency. The patients remained in the angiography room during the procedure, which included 40 min of occlusion time.



View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. Balloon-occluded retrograde transvenous sclerosis. Drawing shows that coaxial microcatheter (short arrow) is selectively inserted into gastric varices through inflated balloon catheter (long arrow) in balloon-occluded retrograde transvenous sclerosis. Sclerosant is then directly injected into gastric varices (shaded area). Forty minutes after injection of sclerosant, as much of residual sclerosant as possible is withdrawn. IVC = inferior vena cava.

 


Results
Top
Introduction
Materials and Methods
Results
Discussion
References
 
We successfully performed balloon-occluded retrograde sclerosis, using a coaxial microcatheter in 12 (80%) of 15 patients. In three patients, we could not insert a microcatheter into the gastric varices because of prominent tortuosity of the gastrorenal shunt vessel, and thus we performed the standard method without a microcatheter. Gastric varices disappeared in 10 (83%) of 12 patients, and no evidence of recurrence was recognized during the follow-up period (Fig. 2A,2B,2C). In 10 patients, in whom balloon-occluded retrograde sclerosis was effective, the mean of the maximum diameter of varices was 7 mm, whereas in two patients in whom the procedure was not effective, the diameters of varices were 18 and 20 mm.



View larger version (144K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. Balloon-occluded retrograde sclerosis with coaxial microcatheter in 75-year-old woman with gastric varices associated with liver cirrhosis. Portal phase of superior mesenteric angiogram shows prominent gastric varices (straight arrows) draining into left renal vein (curved arrow). Portal vein trunk is markedly narrowed (arrowheads).

 


View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. Balloon-occluded retrograde sclerosis with coaxial microcatheter in 75-year-old woman with gastric varices associated with liver cirrhosis. Digital radiograph shows microcatheter being advanced into gastric varices through inflated balloon catheter.

 


View larger version (125K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C. Balloon-occluded retrograde sclerosis with coaxial microcatheter in 75-year-old woman with gastric varices associated with liver cirrhosis. Portal phase of superior mesenteric angiogram obtained after procedure shows selective obliteration of portion of gastric varices (arrows) that protrude into gastric lumen.

 

The mean amount of injected 5% ethanolamine oleate was 25 mL, in the range of 16-35 mL. Collateral vessels that were small in diameter and few in number were easily occluded by injection of the sclerosant. Embolization of collateral vessels with spring coils was not needed in any of the patients. Complications associated with this procedure, mild epigastric pain and transient hemoglobinuria, were present in all 12 patients. Epigastralgia and hemoglobinuria were transient and had almost disappeared by the end of procedure and during the following 24 hr, respectively.

Patency of the gastrorenal shunt vessels was confirmed in eight of 12 patients with contrast-enhanced CT performed after the procedure. In the 10 patients in whom sclerotherapy was effective, endoscopic examination performed during the follow-up period showed no evidence of regrowth of varices.


Discussion
Top
Introduction
Materials and Methods
Results
Discussion
References
 
Thirty-nine percent of gastric varices drain to the left renal vein through the gastrorenal shunt vessel, and we can insert the catheter IV into the gastric varices in such patients. Balloon-occluded retrograde sclerosis has been applied for the treatment of gastric varices, with a high success rate ranging from 75% to 100% reported in the recent literature [1,2,3,4,5,6]. Balloon-occluded retrograde sclerosis could be an option for those patients who are bleeding from gastric varices, have gastrorenal shunts, and who are not good candidates for a transjugular intrahepatic portosystemic shunt procedure (i.e., patients with severe liver failure, high acute physiology and chronic health evaluation II score, right heart failure, or a small or thrombosed portal vein).

In comparison with the standard procedure, balloon-occluded retrograde sclerosis with a coaxial microcatheter provides the following benefits. In the standard method, retrograde injection of sclerosant with positive pressure to fill the gastric varices may be associated with some risk of variceal rupture, whereas with our method, the gastric varices can be directly filled with sclerosant. Our method allows the selective obliteration of the gastric varices, retaining the patent gastrorenal shunt.

When balloon-occluded retrograde sclerosis is applied for the treatment of bleeding from gastric varices rather than for that of hepatic encephalopathy, obliteration of the limited portion of the varices protruding into the gastric lumen is sufficient. The gastrorenal shunt vessels should remain patent because obliteration of these vessels may result in aggravation of the existing esophageal varices and massive ascites due to rapid increase in portal venous pressure. Aggravation of esophageal varices has been reported in 10% to 16% of patients after the procedure [1, 2, 4,5,6], but it was not present in our patients.

In the standard procedure, embolization is occasionally performed on the branches of the gastrorenal shunt vessels, including the inferior phrenic vein, the phrenicocardinal vein, and the adrenal vein, to prevent inflow of ethanolamine oleate to the systemic circulation. In our method, a microcatheter is advanced into the gastric varices beyond most of these collateral branches, and we can avoid embolization before sclerotherapy.

In our sclerotherapy localized to gastric varices, we can reduce the amount of sclerosant to fill the varices, and we can additionally inject a small amount of sclerosant during the procedure to maintain a high concentration of sclerosant in the varices. With the traditional method, withdrawal of the sclerosant through the balloon catheter is occasionally difficult because the catheter tip attaches to the vascular wall. In our method, we can efficiently withdraw sclerosant, using a microcatheter and changing its position.

In two patients with varices of large size (18 and 20 mm in diameter), balloon-occluded retrograde transvenous obliteration was not effective, and some modification of the procedure, such as prolongation of the occlusion time or an increase in the amount of sclerosant, may be needed.

Although the number of subjects in our report is limited and further evaluation is needed, the major advantage of our procedure is that one can sclerose the varices while still retaining the patent shunt vessels.


References
Top
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Koito K, Namieno T, Nakagawa T, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collateral. AJR 1996;167:1317 -1320[Abstract/Free Full Text]
  2. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol 1998;21:27 -30[Medline]
  3. Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol 1999;94:643 -649[Medline]
  4. Kiyosue H, Matsumoto S, Onishi R, et al. Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems [in Japanese]. Nippon Igaku Hoshansen Gakki Zasshi 1999;59:12 -19
  5. Hirota S, Matsumoto S, Tomita M, et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999;211:349 -356[Abstract/Free Full Text]
  6. Hirota S, Fukuda T, Matsumoto S, et al. Balloon-occluded retrograde transvenous obliteration (B-TRO) for portal hypertension [in Japanese]. Nippon Igaku Hoshansen Gakki Zasshi 2000;60:361 -367

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadioGraphicsHome page
H. Kiyosue, H. Mori, S. Matsumoto, Y. Yamada, Y. Hori, and Y. Okino
Transcatheter Obliteration of Gastric Varices: Part 1. Anatomic Classification
RadioGraphics, July 1, 2003; 23(4): 911 - 920.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. Kiyosue, H. Mori, S. Matsumoto, Y. Yamada, Y. Hori, and Y. Okino
Transcatheter Obliteration of Gastric Varices: Part 2. Strategy and Techniques Based on Hemodynamic Features
RadioGraphics, July 1, 2003; 23(4): 921 - 937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. Matsumoto, H. Matsumoto, H. Yamauchi, and K. Takahashi
What Is Adequate Treatment for Gastric Fundal Varices Associated with a Gastrorenal Shunt?
Am. J. Roentgenol., July 1, 2002; 179 (1): 274 - 275.
[Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, K.
Right arrow Articles by Aburano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, K.
Right arrow Articles by Aburano, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS